Literature DB >> 24789092

The FDA and 23andMe: violating the First Amendment or protecting the rights of consumers?

Linnea M Baudhuin1.   

Abstract

Mesh：

Year:  2014        PMID： 24789092     DOI： 10.1373/clinchem.2014.223321

Source DB:  PubMed          Journal:  Clin Chem        ISSN： 0009-9147            Impact factor:   8.327


× No keyword cloud information.
  4 in total

Review 1.  Considerations for developing regulations for direct-to-consumer genetic testing: a scoping review using the 3-I framework.

Authors:  Alexandra Cernat; Naazish S Bashir; Wendy J Ungar
Journal:  J Community Genet       Date:  2022-02-16

2.  The hidden harm behind the return of results from personal genome services: a need for rigorous and responsible evaluation.

Authors:  A Cecile J W Janssens
Journal:  Genet Med       Date:  2014-11-20       Impact factor: 8.822

3.  The audacity of interpretation: Protecting patients or piling on?

Authors:  Misha Angrist
Journal:  Appl Transl Genom       Date:  2014-09-01

4.  "CRISPR for Disabilities: How to Self-Regulate" or Something?

Authors:  Amanda Courtright-Lim
Journal:  J Bioeth Inq       Date:  2022-04-01       Impact factor: 1.352
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.